News
A randomized phase II trial of oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results